Please login to the form below

Not currently logged in
Email:
Password:

Alcon

This page shows the latest Alcon news and features for those working in and with pharma, biotech and healthcare.

Latest news

More from news
Approximately 17 fully matching, plus 52 partially matching documents found.

Latest Intelligence

  • Deal Watch November 2016 Deal Watch November 2016

    To date it seems Sanofi is also considering a move. Meanwhile Novartis is reportedly considering a sale of its contact lens business which is part of the Alcon eye care division.

  • Pharma deals during April 2014 Pharma deals during April 2014

    Remaining revenues will come from pharmaceuticals, eye care (Alcon) and generics (Sandoz) and of course its stake in GSK Consumer Health.

  • Healthcare industry apps Healthcare industry apps

    Developed by Alcon (a Novartis company) this comprehensive tool is designed to teach doctors how to make diagnoses using an ophthalmoscope.

  • Interview: Joseph Jimenez, Novartis Interview: Joseph Jimenez, Novartis

    Our new eye-care business Alcon is also driving our growth, with net sales increasing six per cent in Q2.". ... Alcon is already delivering solid sales growth, with sales up six per cent on a proforma basis in the second quarter.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 10 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics